Heleen Maurice-Stam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Heleen Maurice-Stam has a total of 246 co-authors. Here are the top co-authors by number of shared publications:
Leontien C. M. Kremer
Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands
9 shared publications- Martha A. Grootenhuis
Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands
9 shared publications Wim J. E. Tissing
Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands
8 shared publicationsAndrica C. H. de Vries
Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands
7 shared publicationsDorine Bresters
Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands
7 shared publicationsHelena J. H. van der Pal
Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands
7 shared publications
Latest Publications
- Open Access
- 6 June 2026
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 10 (1)
Critical appraisal of patient-reported and clinician-reported outcome measures assessing functional outcomes in lower extremity bone sarcoma patients—a COSMIN-based systematic review
Purpose: Local therapy for bone sarcoma often significantly impacts patients’ physical abilities and participation in daily life, which underscores the need for accurate assessment of these outcomes to guide optimal care. This study aims to 1) evaluate the measurement properties of eight patient- and clinician-reported outcome measures identified in a recent systematic review (2024) as being used more than once in this population, and 2) recommend the most suitable instruments for evaluation in clinic and research. Methods: We searched MEDLINE and Embase in July 2024 for studies assessing the development and/or measurement properties of the original version of the Baeck equestionnaire, Functional Mobility Assessment, Karnofsky Performance Status, Mankin score, MusculoSkeletal Tumor Society 1987 and 1993-Lower extremity (LE)scores, Reintegration to Normal Living (RNL) Index and Toronto Extremity Salvage Score (TESS) – LE. Full text availability was required. Measurement instruments were evaluated using COSMIN guidelines (July 2024 – January 2025). Results: Seventy-three articles evaluating measurement properties of one of the eight instruments were included. The Baecke questionnaire, RNL Index and TESS-LE had clearly defined constructs of which only the RNL Index and TESS-LE demonstrated sufficient overall content validity (low- and moderate-quality evidence). The remaining instruments lacked clear construct definitions, resulting in indeterminate or insufficient content validity, and therefore cannot be recommended for use. Structural validity of the TESS-LE was inconsistent leading to indeterminate internal consistency, currently preventing its recommendation. Additionally, the evidence supporting sufficient measurement properties of the RNL Index was too limited to justify its use. Conclusion: A clearly defined construct is the cornerstone of a measurement instrument and was lacking in most cases. The TESS-LE and RNL Index show promise due to their sufficient content validity, but require further refinement before they can be recommended as standard instruments to assess physical abilities and participation in daily life in bone sarcoma patients. Advancing measurement of these outcomes requires comprehensive validation and refinement of existing instruments to overcome their current limitations, or the development of new, reliable, and valid instruments tailored to this population. Registration: Study protocol registration in the PROSPERO database:CRD42022353668.
- 6 June 2026
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 10 (1)
Open AccessCritical appraisal of patient-reported and clinician-reported outcome measures assessing functional outcomes in lower extremity bone sarcoma patients—a COSMIN-based systematic review
Purpose: Local therapy for bone sarcoma often significantly impacts patients’ physical abilities and participation in daily life, which underscores the need for accurate assessment of these outcomes to guide optimal care. This study aims to 1) evaluate the measurement properties of eight patient- and clinician-reported outcome measures identified in a recent systematic review (2024) as being used more than once in this population, and 2) recommend the most suitable instruments for evaluation in clinic and research. Methods: We searched MEDLINE and Embase in July 2024 for studies assessing the development and/or measurement properties of the original version of the Baeck equestionnaire, Functional Mobility Assessment, Karnofsky Performance Status, Mankin score, MusculoSkeletal Tumor Society 1987 and 1993-Lower extremity (LE)scores, Reintegration to Normal Living (RNL) Index and Toronto Extremity Salvage Score (TESS) – LE. Full text availability was required. Measurement instruments were evaluated using COSMIN guidelines (July 2024 – January 2025). Results: Seventy-three articles evaluating measurement properties of one of the eight instruments were included. The Baecke questionnaire, RNL Index and TESS-LE had clearly defined constructs of which only the RNL Index and TESS-LE demonstrated sufficient overall content validity (low- and moderate-quality evidence). The remaining instruments lacked clear construct definitions, resulting in indeterminate or insufficient content validity, and therefore cannot be recommended for use. Structural validity of the TESS-LE was inconsistent leading to indeterminate internal consistency, currently preventing its recommendation. Additionally, the evidence supporting sufficient measurement properties of the RNL Index was too limited to justify its use. Conclusion: A clearly defined construct is the cornerstone of a measurement instrument and was lacking in most cases. The TESS-LE and RNL Index show promise due to their sufficient content validity, but require further refinement before they can be recommended as standard instruments to assess physical abilities and participation in daily life in bone sarcoma patients. Advancing measurement of these outcomes requires comprehensive validation and refinement of existing instruments to overcome their current limitations, or the development of new, reliable, and valid instruments tailored to this population. Registration: Study protocol registration in the PROSPERO database:CRD42022353668.
- Open Access
- 5 November 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 90, 103622
A multidisciplinary approach to assessing the impact of local therapy in pediatric bone sarcoma patients and survivors: a cross-sectional study of adverse events and health-related quality of life
- 5 November 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 90, 103622
Open AccessA multidisciplinary approach to assessing the impact of local therapy in pediatric bone sarcoma patients and survivors: a cross-sectional study of adverse events and health-related quality of life
- Open Access
- 1 August 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (10) , e31955
Posttraumatic Stress Symptoms in Children and Parents Shortly After Pediatric Brain Tumor Diagnosis: Prevalence and Risk Factors
Background: Posttraumatic stress symptoms (PTSS) are high amongst survivors of pediatric brain tumors and their parents; however, early prevalence is unknown. This study aimed to get insight into the prevalence and risk factors of child and parental PTSS shortly after diagnosis.Procedures: Sixty‐five children with brain tumors (6–16 years old) and their parents participated. The prevalence of clinical child PTSS (CRIES‐13 self‐ and proxy‐report) and parental PTSS (PCL‐5) was assessed 1–3 months after diagnosis, and compared to the general population (PCL‐5; binomial test). Pearson's correlations between child and parental PTSS were calculated. Risk factors were explored with linear regression analyses (psychosocial risk assessed through PAT).Results: Clinical child PTSS scores were reported by 29.4% of the children (self‐report) and 11.1% of their parents (proxy‐report). Prevalence of clinical parental PTSS was not significantly higher than in the general population (mothers: 12.1%, p = 0.07; fathers: 6.0%, p = 0.20). Self‐reported child PTSS scores were associated with proxy‐reported child PTSS scores (r = 0.49, p < 0.001), but not with parental PTSS scores (mother r = 0.22, father r = 0.18). No associations were found between demographic factors and child or parental PTSS. Shorter time since diagnosis was associated with more self‐reported child PTSS (β = −0.45, p = 0.01). Starting radiotherapy was associated with more mother PTSS (β = 1.04, p < 0.003). Family psychosocial risk was associated with more child PTSS (self‐report β = 0.82, p = 0.02; proxy‐report β = 0.81, p = 0.02) and mother PTSS (β = 1.33, p < 0.001).Conclusions: Prevalence of PTSS in children with recently diagnosed brain tumors was high, highlighting the need for early psychosocial monitoring and targeted interventions to optimize health‐related quality of life.
- 1 August 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (10) , e31955
Open AccessPosttraumatic Stress Symptoms in Children and Parents Shortly After Pediatric Brain Tumor Diagnosis: Prevalence and Risk Factors
Background: Posttraumatic stress symptoms (PTSS) are high amongst survivors of pediatric brain tumors and their parents; however, early prevalence is unknown. This study aimed to get insight into the prevalence and risk factors of child and parental PTSS shortly after diagnosis.Procedures: Sixty‐five children with brain tumors (6–16 years old) and their parents participated. The prevalence of clinical child PTSS (CRIES‐13 self‐ and proxy‐report) and parental PTSS (PCL‐5) was assessed 1–3 months after diagnosis, and compared to the general population (PCL‐5; binomial test). Pearson's correlations between child and parental PTSS were calculated. Risk factors were explored with linear regression analyses (psychosocial risk assessed through PAT).Results: Clinical child PTSS scores were reported by 29.4% of the children (self‐report) and 11.1% of their parents (proxy‐report). Prevalence of clinical parental PTSS was not significantly higher than in the general population (mothers: 12.1%, p = 0.07; fathers: 6.0%, p = 0.20). Self‐reported child PTSS scores were associated with proxy‐reported child PTSS scores (r = 0.49, p < 0.001), but not with parental PTSS scores (mother r = 0.22, father r = 0.18). No associations were found between demographic factors and child or parental PTSS. Shorter time since diagnosis was associated with more self‐reported child PTSS (β = −0.45, p = 0.01). Starting radiotherapy was associated with more mother PTSS (β = 1.04, p < 0.003). Family psychosocial risk was associated with more child PTSS (self‐report β = 0.82, p = 0.02; proxy‐report β = 0.81, p = 0.02) and mother PTSS (β = 1.33, p < 0.001).Conclusions: Prevalence of PTSS in children with recently diagnosed brain tumors was high, highlighting the need for early psychosocial monitoring and targeted interventions to optimize health‐related quality of life.
- Open Access
- 22 July 2025
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 40 (8) , 1501-1510
Screening for Neurocognitive Deficits in Pediatrics—the Clinical Utility of the Pediatric Perceived Cognitive Functioning item bank
Objective: Efficient screening for neurocognitive dysfunction is pivotal for timely intervention in at-risk populations in pediatrics. The Pediatric Perceived Cognitive Functioning (PedsPCF) item bank was developed for this purpose. We aimed to explore the relationship between, and the discriminative value of PedsPCF scores with neurocognitive outcomes and the behavior rating inventory of executive function parent report (BRIEF) in a pediatric population. Methods: The PedsPCF parent- and self-report versions were added to neurocognitive testing batteries that were administered in clinical care or research in two Dutch academic pediatric hospitals. Most test batteries were individually tailored, resulting in a wide variety of measures. We determined Pearson correlations between the PedsPCF and neurocognitive test outcomes categorized into five neurocognitive domains as proposed in the Diagnostic and Statistical Manual of Mental Disorders-5, and the BRIEF-parent. Moreover, we assessed the discriminative values of PedsPCF deficit scores (M - 1 SD) for neurocognitive domain deficits (M - 1 SD) and the BRIEF-parent. Results: The PedsPCF was completed by 104 children and 106 parents. The parent-PedsPCF correlated with three neurocognitive domains and the BRIEF-parent but did not indicate deficits in any of the neurocognitive domains. The self-report PedsPCF correlated with a deficit in complex attention and the BRIEF-parent, and could indicate a deficit in complex attention only. Conclusions: Although the PedsPCF correlated with neurocognitive test outcomes, the discriminative value of the total score was limited. The short and freely available PedsPCF appears to add a useful subjective dimension to neurocognitive testing rather than a replacement of neurocognitive assessment.
- 22 July 2025
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 40 (8) , 1501-1510
Open AccessScreening for Neurocognitive Deficits in Pediatrics—the Clinical Utility of the Pediatric Perceived Cognitive Functioning item bank
Objective: Efficient screening for neurocognitive dysfunction is pivotal for timely intervention in at-risk populations in pediatrics. The Pediatric Perceived Cognitive Functioning (PedsPCF) item bank was developed for this purpose. We aimed to explore the relationship between, and the discriminative value of PedsPCF scores with neurocognitive outcomes and the behavior rating inventory of executive function parent report (BRIEF) in a pediatric population. Methods: The PedsPCF parent- and self-report versions were added to neurocognitive testing batteries that were administered in clinical care or research in two Dutch academic pediatric hospitals. Most test batteries were individually tailored, resulting in a wide variety of measures. We determined Pearson correlations between the PedsPCF and neurocognitive test outcomes categorized into five neurocognitive domains as proposed in the Diagnostic and Statistical Manual of Mental Disorders-5, and the BRIEF-parent. Moreover, we assessed the discriminative values of PedsPCF deficit scores (M - 1 SD) for neurocognitive domain deficits (M - 1 SD) and the BRIEF-parent. Results: The PedsPCF was completed by 104 children and 106 parents. The parent-PedsPCF correlated with three neurocognitive domains and the BRIEF-parent but did not indicate deficits in any of the neurocognitive domains. The self-report PedsPCF correlated with a deficit in complex attention and the BRIEF-parent, and could indicate a deficit in complex attention only. Conclusions: Although the PedsPCF correlated with neurocognitive test outcomes, the discriminative value of the total score was limited. The short and freely available PedsPCF appears to add a useful subjective dimension to neurocognitive testing rather than a replacement of neurocognitive assessment.
- Open Access
- 13 February 2025
- Published by Wiley in Psycho-Oncology
- Vol. 34 (2) , e70101
The Prevalence and Associated Factors of Cancer‐Related Worries in Adult Survivors of Childhood Cancer: A Systematic Review
Background: Many childhood cancer survivors (CCS) experience cancer‐related worries (CRW), for example about late effects and cancer recurrence. CRW are associated with lower quality of life (QoL) and maladaptive health care use. We examined the prevalence, severity, and factors associated with CRW in adult CCS.Methods: We included quantitative studies of ≥ 100 participants reporting on prevalence, severity, mean scores and/or associated factors of CRW among CCS aged ≥ 18 years, diagnosed at ≤ 21 years, and ≥ 2 years post‐diagnosis. We searched MEDLINE/PubMed and APA PsycINFO, hand‐searched reference lists, and consulted experts. Risk of bias was assessed using the Cochrane Childhood Cancer Risk of Bias Criteria. Results were synthesized descriptively.Results: The 17 included studies with a total of 26,306 CCS identified three main themes of CRW: health‐related, financial, and interpersonal. Most prevalent were health‐related worries regarding future health (88%–92%), late effects (83%), cancer recurrence (25%–88%), second cancers (50%–91%), and infertility (34%–68%). Factors associated with increased CRW varied depending on the specific CRW. These included female sex, more pain, anxiety, depression, chronic conditions (e.g., neurologic, being overweight), and treatment history (chemotherapy, radiotherapy).Discussion and implications: Although most included studies used single items to assess CRW, this review underscores that health‐related worries are particularly prevalent among CCS. Effectively identifying CCS at high risk, for example through using validated measures, and addressing severe CRW can facilitate adaptive healthcare use and improve QoL among CCS. Potential interventions can be providing information about late effects, psycho‐education, discussions during follow‐up care, and targeted psychosocial support for those with severe CRW.
- 13 February 2025
- Published by Wiley in Psycho-Oncology
- Vol. 34 (2) , e70101
Open AccessThe Prevalence and Associated Factors of Cancer‐Related Worries in Adult Survivors of Childhood Cancer: A Systematic Review
Background: Many childhood cancer survivors (CCS) experience cancer‐related worries (CRW), for example about late effects and cancer recurrence. CRW are associated with lower quality of life (QoL) and maladaptive health care use. We examined the prevalence, severity, and factors associated with CRW in adult CCS.Methods: We included quantitative studies of ≥ 100 participants reporting on prevalence, severity, mean scores and/or associated factors of CRW among CCS aged ≥ 18 years, diagnosed at ≤ 21 years, and ≥ 2 years post‐diagnosis. We searched MEDLINE/PubMed and APA PsycINFO, hand‐searched reference lists, and consulted experts. Risk of bias was assessed using the Cochrane Childhood Cancer Risk of Bias Criteria. Results were synthesized descriptively.Results: The 17 included studies with a total of 26,306 CCS identified three main themes of CRW: health‐related, financial, and interpersonal. Most prevalent were health‐related worries regarding future health (88%–92%), late effects (83%), cancer recurrence (25%–88%), second cancers (50%–91%), and infertility (34%–68%). Factors associated with increased CRW varied depending on the specific CRW. These included female sex, more pain, anxiety, depression, chronic conditions (e.g., neurologic, being overweight), and treatment history (chemotherapy, radiotherapy).Discussion and implications: Although most included studies used single items to assess CRW, this review underscores that health‐related worries are particularly prevalent among CCS. Effectively identifying CCS at high risk, for example through using validated measures, and addressing severe CRW can facilitate adaptive healthcare use and improve QoL among CCS. Potential interventions can be providing information about late effects, psycho‐education, discussions during follow‐up care, and targeted psychosocial support for those with severe CRW.
- Open Access
- 2 October 2024
- Published by Wiley in Psycho-Oncology
- Vol. 33 (10) , e9313
Risk and Protective Factors of Psychosocial Functioning in Survivors of Childhood Cancer: Results of the DCCSS‐LATER Study
Objective: This study examines the association between psychosocial risk and protective factors and a wide range of psychosocial outcomes including emotional, social, cognitive, and physical domains in childhood cancer survivors (CCS).Methods: CCS from the Dutch Childhood Cancer Survivor Study (DCCSS)‐LATER cohort (diagnosed 1963–2001) part 2 (age ≥ 18 years, diagnosed < 18 years, ≥ 5 years since diagnosis) completed questionnaires on psychosocial risk and protective factors (Benefit and Burden Scale, Illness Cognition Questionnaire, Rosenberg Self‐Esteem Scale, and Impact of Cancer Scale), and psychosocial outcomes (Hospital Anxiety and Depression Scale, Self‐Rating Scale for Post‐Traumatic Stress Disorder, TNO‐AZL Questionnaire for Adult Health‐Related Quality of Life, and Short Form‐36). Associations were assessed with regression analysis, adjusting for attained age, sex, number of health conditions, and time since diagnosis, while correcting for multiple testing (p < 0.004).Results: A total of 1382 CCS participated, all diagnosed ≥ 15 years ago. The mean age of participating CCS was 36 years, and 51% were female. Perceived benefit and burden, acceptance, and helplessness, self‐esteem and social support were associated with the psychosocial outcomes. In the models including all psychosocial factors, most associations with psychosocial outcomes were seen for self‐esteem (10×), and perceived burden (9×). Self‐esteem (all β ≤ 0.47) and perceived burden (all β ≤ 0.38) demonstrated strongest associations of medium/large size.Conclusions: Perceptions of childhood cancer, illness cognitions, self‐esteem, and social support play a role in explaining psychosocial functioning in CCS, outweighing the influence of socio‐demographic and medical variables. Addressing negative perceptions and reducing feelings of helplessness, while promoting acceptance, self‐esteem, and social support, could provide intervention targets for CCS who encounter psychosocial challenges.
- 2 October 2024
- Published by Wiley in Psycho-Oncology
- Vol. 33 (10) , e9313
Open AccessRisk and Protective Factors of Psychosocial Functioning in Survivors of Childhood Cancer: Results of the DCCSS‐LATER Study
Objective: This study examines the association between psychosocial risk and protective factors and a wide range of psychosocial outcomes including emotional, social, cognitive, and physical domains in childhood cancer survivors (CCS).Methods: CCS from the Dutch Childhood Cancer Survivor Study (DCCSS)‐LATER cohort (diagnosed 1963–2001) part 2 (age ≥ 18 years, diagnosed < 18 years, ≥ 5 years since diagnosis) completed questionnaires on psychosocial risk and protective factors (Benefit and Burden Scale, Illness Cognition Questionnaire, Rosenberg Self‐Esteem Scale, and Impact of Cancer Scale), and psychosocial outcomes (Hospital Anxiety and Depression Scale, Self‐Rating Scale for Post‐Traumatic Stress Disorder, TNO‐AZL Questionnaire for Adult Health‐Related Quality of Life, and Short Form‐36). Associations were assessed with regression analysis, adjusting for attained age, sex, number of health conditions, and time since diagnosis, while correcting for multiple testing (p < 0.004).Results: A total of 1382 CCS participated, all diagnosed ≥ 15 years ago. The mean age of participating CCS was 36 years, and 51% were female. Perceived benefit and burden, acceptance, and helplessness, self‐esteem and social support were associated with the psychosocial outcomes. In the models including all psychosocial factors, most associations with psychosocial outcomes were seen for self‐esteem (10×), and perceived burden (9×). Self‐esteem (all β ≤ 0.47) and perceived burden (all β ≤ 0.38) demonstrated strongest associations of medium/large size.Conclusions: Perceptions of childhood cancer, illness cognitions, self‐esteem, and social support play a role in explaining psychosocial functioning in CCS, outweighing the influence of socio‐demographic and medical variables. Addressing negative perceptions and reducing feelings of helplessness, while promoting acceptance, self‐esteem, and social support, could provide intervention targets for CCS who encounter psychosocial challenges.
- Open Access
- 31 March 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (6) , e30951
Different subtypes of chronic fatigue in childhood cancer survivors: A DCCSS LATER study
Introduction: The aim of the current study was to investigate whether subtypes of chronic fatigue (CF) can be identified in childhood cancer survivors (CCS), and if so, to determine the characteristics of participants with a specific subtype.Methods: Participants were included from the nationwide DCCSS LATER cohort. The Checklist Individual Strength (CIS) was completed to assess fatigue. Participants with CF (scored ≥35 on the fatigue severity subscale and indicated to suffer from fatigue for ≥6 months) were divided into subgroups using two‐step cluster analysis based on the CIS concentration, motivation, and physical activity subscales. Differences between groups on demographics, psychosocial, lifestyle, and treatment‐related variables were determined using ANOVA and chi‐square analyses (univariable) and multinomial regression analysis (multivariable).Results: A total of 1910 participants participated in the current study (n = 450 with CF; n = 1460 without CF). Three CF subgroups were identified: Subgroup 1 (n = 133, 29% of participants) had CF with problems in physical activity; Subgroup 2 (n = 111, 25% of participants) had CF with difficulty concentrating; and Subgroup 3 (n = 206, 46% of participants) had multi‐dimensional CF. Compared to Subgroup 1, Subgroup 2 more often reported sleep problems, limitations in social functioning, and less often have more than two comorbidities. Subgroup 3 more often reported depression, sleep problems, a lower self‐esteem, and limitations in social functioning and a lower educational level compared to Subgroup 1.Conclusion: Different subgroups of CCS with CF can be identified based on fatigue dimensions physical activity, motivation and concentration. Results suggest that different intervention strategies, tailored for each subgroup, might be beneficial.
- 31 March 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (6) , e30951
Open AccessDifferent subtypes of chronic fatigue in childhood cancer survivors: A DCCSS LATER study
Introduction: The aim of the current study was to investigate whether subtypes of chronic fatigue (CF) can be identified in childhood cancer survivors (CCS), and if so, to determine the characteristics of participants with a specific subtype.Methods: Participants were included from the nationwide DCCSS LATER cohort. The Checklist Individual Strength (CIS) was completed to assess fatigue. Participants with CF (scored ≥35 on the fatigue severity subscale and indicated to suffer from fatigue for ≥6 months) were divided into subgroups using two‐step cluster analysis based on the CIS concentration, motivation, and physical activity subscales. Differences between groups on demographics, psychosocial, lifestyle, and treatment‐related variables were determined using ANOVA and chi‐square analyses (univariable) and multinomial regression analysis (multivariable).Results: A total of 1910 participants participated in the current study (n = 450 with CF; n = 1460 without CF). Three CF subgroups were identified: Subgroup 1 (n = 133, 29% of participants) had CF with problems in physical activity; Subgroup 2 (n = 111, 25% of participants) had CF with difficulty concentrating; and Subgroup 3 (n = 206, 46% of participants) had multi‐dimensional CF. Compared to Subgroup 1, Subgroup 2 more often reported sleep problems, limitations in social functioning, and less often have more than two comorbidities. Subgroup 3 more often reported depression, sleep problems, a lower self‐esteem, and limitations in social functioning and a lower educational level compared to Subgroup 1.Conclusion: Different subgroups of CCS with CF can be identified based on fatigue dimensions physical activity, motivation and concentration. Results suggest that different intervention strategies, tailored for each subgroup, might be beneficial.
- Open Access
Implementation of the Short-Form 36 (SF-36) in childhood cancer survivors: An analysis on measurement properties across 5 European countries
Purpose The Short Form-36 (SF-36) is widely used in many research contexts and cultures to assess health-related quality of life (HRQOL). We investigated the measurement properties of the SF-36 in a large cohort study among childhood cancer survivors living in 5 European countries. Methods The PanCareLIFE project includes adult survivors of childhood cancer living in the Czech Republic, France, Germany, The Netherlands, and Switzerland. We invited 19,268 survivors aged >18 years, and 10,077 (53%) returned questionnaires. Of these, 9,871 (98%) were included in the analyses. We assessed HRQOL with the SF-36 version 1 (V1) or version 2 (V2) and investigated its performance. We analysed data completeness, floor and ceiling effects, item-internal consistency, item-discriminant validity, reliability, and scaling assumptions focusing on country-and version-specific differences. Results Data completeness was high but differed between countries (90% in the Czech Republic to 96% in France). Floor effects were negligible, but ceiling effects in 5 out of 8 SF-36 scales were present (50-70%). V2 had slightly fewer ceiling effects than V1 in 2 scales. Item-internal consistency, item-discriminant validity, and reliability were good. Scaling assumptions were met, with 4 scales representing strong mental health content, and the other 4 representing strong physical health content. Conclusion The SF-36 (V1 and V2) provided robust measurement properties among childhood cancer survivors, and differences in study design across the 5 European countries did not affect measurement properties. Researchers need to take into account that ceiling effects exist which might limit sensitivity among participants who fared particularly well. PLAIN ENGLISH SUMMARY This study investigated how well the Short Form-36 (SF-36), a commonly used tool for assessing health-related quality of life, performs in childhood cancer survivors from five different European countries. We looked at the amount of survivors answering to all of the SF-36 questions, how many indicated the most positive or the most negative answer category, whether the questions were consistent within the different aspects of the questionnaire and how consistent and dependable it measured quality of life in the survivors. We found that overall, the SF-36 measured health-related quality of life well in all the countries. This is reassuring for researchers considering its use in studies involving multiple centers across Europe.
Open AccessImplementation of the Short-Form 36 (SF-36) in childhood cancer survivors: An analysis on measurement properties across 5 European countries
Purpose The Short Form-36 (SF-36) is widely used in many research contexts and cultures to assess health-related quality of life (HRQOL). We investigated the measurement properties of the SF-36 in a large cohort study among childhood cancer survivors living in 5 European countries. Methods The PanCareLIFE project includes adult survivors of childhood cancer living in the Czech Republic, France, Germany, The Netherlands, and Switzerland. We invited 19,268 survivors aged >18 years, and 10,077 (53%) returned questionnaires. Of these, 9,871 (98%) were included in the analyses. We assessed HRQOL with the SF-36 version 1 (V1) or version 2 (V2) and investigated its performance. We analysed data completeness, floor and ceiling effects, item-internal consistency, item-discriminant validity, reliability, and scaling assumptions focusing on country-and version-specific differences. Results Data completeness was high but differed between countries (90% in the Czech Republic to 96% in France). Floor effects were negligible, but ceiling effects in 5 out of 8 SF-36 scales were present (50-70%). V2 had slightly fewer ceiling effects than V1 in 2 scales. Item-internal consistency, item-discriminant validity, and reliability were good. Scaling assumptions were met, with 4 scales representing strong mental health content, and the other 4 representing strong physical health content. Conclusion The SF-36 (V1 and V2) provided robust measurement properties among childhood cancer survivors, and differences in study design across the 5 European countries did not affect measurement properties. Researchers need to take into account that ceiling effects exist which might limit sensitivity among participants who fared particularly well. PLAIN ENGLISH SUMMARY This study investigated how well the Short Form-36 (SF-36), a commonly used tool for assessing health-related quality of life, performs in childhood cancer survivors from five different European countries. We looked at the amount of survivors answering to all of the SF-36 questions, how many indicated the most positive or the most negative answer category, whether the questions were consistent within the different aspects of the questionnaire and how consistent and dependable it measured quality of life in the survivors. We found that overall, the SF-36 measured health-related quality of life well in all the countries. This is reassuring for researchers considering its use in studies involving multiple centers across Europe.
- Open Access
- 17 January 2024
- Published by Wiley in Psycho-Oncology
- Vol. 33 (1) , e6284
Efficacy of Op Koers Online, an online group intervention for parents of children with cancer: Results of a randomized controlled trial
Objective: Parents of children with cancer are at risk for developing psychosocial problems. The present study aims to evaluate the effect of an online group intervention (Op Koers Online, in English: On Track Online) on psychosocial wellbeing and coping skills.Methods: Parents of a child with cancer (diagnosis p < 0.05) were found at T1 for anxiety, depression, distress, loneliness and relaxation, and at T2 for anxiety, uncertainty and relaxation. In the intervention condition, scores did not change from T2 to T3, except loneliness that decreased and relaxation that improved. All effect sizes were small to medium (β = −0.21 to 0.46). Parents were generally positive about the intervention.Conclusions: Op Koers Online for parents of children with cancer has a positive effect on psychosocial wellbeing and the coping skill relaxation. Implementation is recommended to prevent psychosocial problems.Clinical Trial Registration: Dutch Trial Register https://onderzoekmetmensen.nl/en NL73763.041.20.
- 17 January 2024
- Published by Wiley in Psycho-Oncology
- Vol. 33 (1) , e6284
Open AccessEfficacy of Op Koers Online, an online group intervention for parents of children with cancer: Results of a randomized controlled trial
Objective: Parents of children with cancer are at risk for developing psychosocial problems. The present study aims to evaluate the effect of an online group intervention (Op Koers Online, in English: On Track Online) on psychosocial wellbeing and coping skills.Methods: Parents of a child with cancer (diagnosis p < 0.05) were found at T1 for anxiety, depression, distress, loneliness and relaxation, and at T2 for anxiety, uncertainty and relaxation. In the intervention condition, scores did not change from T2 to T3, except loneliness that decreased and relaxation that improved. All effect sizes were small to medium (β = −0.21 to 0.46). Parents were generally positive about the intervention.Conclusions: Op Koers Online for parents of children with cancer has a positive effect on psychosocial wellbeing and the coping skill relaxation. Implementation is recommended to prevent psychosocial problems.Clinical Trial Registration: Dutch Trial Register https://onderzoekmetmensen.nl/en NL73763.041.20.
- Open Access
- 11 July 2023
- Published by Wiley in Psycho-Oncology
- Vol. 32 (9) , 1401-1411
Psychosocial functioning of adult siblings of Dutch very long‐term survivors of childhood cancer: DCCSS‐LATER 2 psycho‐oncology study
- 11 July 2023
- Published by Wiley in Psycho-Oncology
- Vol. 32 (9) , 1401-1411
Open AccessPsychosocial functioning of adult siblings of Dutch very long‐term survivors of childhood cancer: DCCSS‐LATER 2 psycho‐oncology study